|
Re: Bypassing the iceberg....Warning, stream on consciousness post
|
4
|
Resverlogix Corp.
|
Feb 11, 2016 09:05AM
|
|
Re: Not adding up!
|
4
|
Zenith Epigenetics
|
Nov 16, 2021 12:18PM
|
|
Re: Recent Funding - Zenith CC
|
4
|
Zenith Epigenetics
|
Oct 22, 2022 10:15AM
|
|
Re: Sept 30 2022 - Resverlogix streaming video
|
4
|
Resverlogix Corp.
|
Oct 03, 2022 07:52PM
|
|
Re: Update from IR -- Eversana paused?
|
4
|
Resverlogix Corp.
|
Dec 20, 2022 10:36AM
|
|
Re: One thing is for sure....
|
4
|
Resverlogix Corp.
|
Nov 06, 2015 10:13AM
|
|
BP buyout appetite for biotech in 2020
|
4
|
Resverlogix Corp.
|
Jan 22, 2020 07:39PM
|
|
Re: Stochs and MACD...looking bullish
|
4
|
Resverlogix Corp.
|
Aug 15, 2015 11:18AM
|
|
Re: Fist stamp of approval from FDA!!!
|
4
|
Resverlogix Corp.
|
Feb 03, 2020 10:18AM
|
|
Re: This is what I think might be going on.....Where there is smoke there is fire
|
4
|
Resverlogix Corp.
|
Sep 13, 2017 02:12PM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
4
|
Zenith Epigenetics
|
Mar 03, 2017 10:01AM
|
|
Re: ASCO 2019 coming up May 31 to June 4
|
4
|
Zenith Epigenetics
|
May 27, 2019 03:38PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
4
|
Resverlogix Corp.
|
Aug 13, 2023 04:18PM
|
|
Re: What is Mr. Market saying about RVX?
|
4
|
Resverlogix Corp.
|
Nov 26, 2018 10:46AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
4
|
Zenith Epigenetics
|
Jul 16, 2017 01:18PM
|
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Feb 06, 2024 11:23AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 09, 2022 12:27PM
|
|
Re: here's one of the newswires
|
4
|
Resverlogix Corp.
|
Jan 12, 2018 12:19PM
|
|
Re: Why have we not heard more about CURATE-AI?
|
4
|
Zenith Epigenetics
|
Mar 25, 2021 05:40PM
|
|
Re: Zenith trial partners
|
4
|
Zenith Epigenetics
|
Jan 29, 2023 03:42PM
|
